EssilorLuxottica : Presentazione dell’Assemblea degli Azionisti

2021 ANNUAL SHAREHOLDERS' MEETING

AGENDA

2

FOR THE ORDINARY MEETING

1. Approval of the 2020 Company financial statements;
2. Approval of the 2020 consolidated financial statements;
3. Allocation of earnings and setting of the dividend;
4. Agreements falling within the scope of Articles L.225-38 and subsequent of the French Commercial Code;
5. Approval of the report on the compensation and benefits in kind paid in 2020 or awarded in respect of 2020 to corporate officers;
6. Approval of the fixed, variable and exceptional components comprising the total compensation and benefits in kind paid in 2020 or awarded in respect of 2020 to Leonardo Del Vecchio, Executive Chairman until December 17, 2020 and Chairman of the Board of Directors from this date;
7. Approval of the fixed, variable and exceptional components comprising the total compensation and benefits in kind paid in 2020 or awarded in respect of 2020 to Hubert Sagnières, Executive Vice- Chairman until December 17, 2020 and Vice-Chairman of the Board of Directors from this date;
8. Approval of the compensation policy applicable to corporate officers for the period from January 1, 2021 to the date of the Annual Shareholders' Meeting;
9. Approval of the compensation policy applicable to corporate officers for the period after the Annual Shareholders' Meeting;
10. Authorization to be granted to the Board of Directors to proceed with the purchase of Company's own ordinary shares.

3

FOR THE EXTRAORDINARY MEETING

1. Harmonization of Articles 4, 9, 11, 14, 16, 23 of the Company's Articles of Association with various provisions, legal and regulatory in particular, of the French Law of May 22, 2019 known as the "Pacte Law" ;
2. Modification of Article 13 of the Company's Articles of Association "Duration of the Directors' term of office";
3. Modifications of Articles 15, 16 and 23 of the Company's Articles of Association following the governance changes;
4. Authorization to be granted to the Board of Directors to reduce the share capital by cancelling Company treasury shares;
5. Authorization to be granted to the Board of Directors to proceed with the award of free existing shares (also called performance shares) to the benefit of members of the employed staff and/or executive officers;
6. Delegation of authority granted to the Board of Directors to issue shares and securities entailing a share capital increase, with preferential subscription rights (ceiling of 5% of the share capital);
7. Delegation of authority granted to the Board of Directors entailing a capital increase by capitalization of premiums, reserves, profits or other rights;
8. Delegation of authority granted to the Board of Directors for the purpose of deciding capital increases reserved for members of a Company Savings Plan (French Plans d'Épargne d'Entreprise or "PEE") without preferential subscription rights (ceiling of 0.5% of the share capital).

4

FOR THE ORDINARY MEETING

1. Renewal of the mandate of Director of Leonardo Del Vecchio;
2. Renewal of the mandate of Director of Romolo Bardin;
3. Renewal of the mandate of Director of Juliette Favre;
4. Renewal of the mandate of Director of Francesco Milleri;
5. Renewal of the mandate of Director of Paul du Saillant;
6. Renewal of the mandate of Director of Cristina Scocchia;
7. Appointment of Jean-Luc Biamonti as Director;
8. Appointment of Marie-ChristineCoisne-Roquette as Director;
9. Appointment of José Gonzalo as Director;
10. Appointment of Swati Piramal as Director;
11. Appointment of Nathalie von Siemens as Director;
12. Appointment of Andrea Zappia as Director;
13. Duration of Directors' mandate;
14. Power to carry out formalities.

5

• THERE IS NO SET FORMULA TO BECOMING AN INVENTOR - YOU HAVE TO BE OBSERVANT AND ALWAYS HAVE AN INQUISITIVE EYE. »

Bernard Maitenaz 1926 - 2021

2021 ANNUAL SHAREHOLDERS' MEETING

FINANCIAL RESULTS

7

RESILIENCE AND AGILITY IN 2020

• A pivotal year for EssilorLuxottica
• COVID-19proves to be a catalyst
• • Outstanding adaptability of employees and customers
  • Client intimacy, supply chain flexibility, new consumer habits
  • Strict financial discipline
• Solid results and cash illustrate key strengths
• • Outperformance in lenses, optometry, optical frames, online, retail
  • Solid pipeline of innovations in major new categories: complete pairs, myopia management, precision optometry, smart glasses
  • Digitalisation acceleration and e-commerce
  • Deepening integration and synergies
• A stronger group, ideally positioned for the future

8

FINANCIAL HIGHLIGHTS FY 2020

AT CURRENT EXCHANGE RATES

REVENUE GROWTH

ADJUSTED OPERATING PROFIT (%)

ADJUSTED NET PROFIT*

FREE CASH FLOW

CASH & SHORT-TERM INVESTMENTS

* Adjusted net profit attributable to the owners of the parent.

FY 2020

-17.0%(curr. ER) -14.6%(const. ER)

9.5%

• 788 mn
• 1.8 bn
• 8.9 bn

9

REVENUE BY REGION, FY 2020

€ million	FY 2020	FY 2019*
North America	7,901	9,146
Europe	3,450	4,239
Asia, Oceania and	2,362	2,891
Africa
Latin America	715	1,114
Total	14,429	17,390

Change at constant	Change at current
exchange rates	exchange rates
-11.8%	-13.6%
-17.5%	-18.6%
-16.4%	-18.3%
-21.9%	-35.8%
-14.6%	-17.0%

* Revenue breakdown revised to reflect a reclassification of certain geographic markets, which the Group considers immaterial.

10